Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1217)
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.83
Total Value
$263.60K
Shares Held After
481,906
% of Holdings
3.8%
Quantum-Si Inc (QSI)
Hawkins Jeffrey Alan — Director
Shares
11,628
Price
$0.85
Total Value
$9.86K
Shares Held After
3,871,996
% of Holdings
0.3%
4D Molecular Therapeutics, Inc. (FDMT)
Gupta Ashoo — VP, Finance and Controller
Shares
80
Price
$8.61
Total Value
$688.80
Shares Held After
47,055
% of Holdings
0.2%
4D Molecular Therapeutics, Inc. (FDMT)
Gupta Ashoo — VP, Finance and Controller
Shares
310
Price
$8.61
Total Value
$2.67K
Shares Held After
46,914
% of Holdings
0.7%
Quantum-Si Inc (QSI)
Keyes Jeffry R. — Chief Financial Officer
Shares
4,233
Price
$0.85
Total Value
$3.59K
Shares Held After
1,811,767
% of Holdings
0.2%
Quantum-Si Inc (QSI)
LaPointe Christian — GC & Corp. Secretary
Shares
5,849
Price
$0.85
Total Value
$4.96K
Shares Held After
1,204,127
% of Holdings
0.5%
Quantum-Si Inc (QSI)
Vieceli John S. — Chief Product Officer
Shares
10,758
Price
$0.85
Total Value
$9.13K
Shares Held After
1,181,896
% of Holdings
0.9%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
11,767
Price
$36.01
Total Value
$423.73K
Shares Held After
2,231
% of Holdings
84.1%
Tarsus Pharmaceuticals, Inc. (TARS)
Neervannan Seshadri — Chief Operating Officer
Shares
2,989
Price
$66.75
Total Value
$199.52K
Shares Held After
82,791
% of Holdings
3.5%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
601
Price
$34.41
Total Value
$20.68K
Shares Held After
19,543
% of Holdings
3.0%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
8,692
Price
$33.64
Total Value
$292.36K
Shares Held After
20,144
% of Holdings
30.1%
BIOCRYST PHARMACEUTICALS INC (BCRX)
HEGGIE THERESA — Director
Shares
49,933
Price
$10.11
Total Value
$504.82K
Shares Held After
65,352
% of Holdings
43.3%
Immunome Inc. (IMNM)
WAGENHEIM PHILIP — Director
Shares
36,800
Price
$20.47
Total Value
$753.30K
Shares Held After
369,347
% of Holdings
9.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.37
Total Value
$254.83K
Shares Held After
486,244
% of Holdings
3.8%
Kalaris Therapeutics, Inc. (KLRS)
Hagen Brett R — Chief Accounting Officer
Shares
1,915
Price
$6.72
Total Value
$12.87K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$529.08
Total Value
$169.30K
Shares Held After
40,513
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
865
Price
$527.99
Total Value
$456.71K
Shares Held After
40,833
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
993
Price
$527.08
Total Value
$523.39K
Shares Held After
41,698
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
660
Price
$526.06
Total Value
$347.20K
Shares Held After
42,691
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,815
Price
$525.02
Total Value
$952.91K
Shares Held After
43,351
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,749
Price
$524.18
Total Value
$1.44M
Shares Held After
45,166
% of Holdings
5.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,538
Price
$523.28
Total Value
$804.81K
Shares Held After
47,915
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$521.69
Total Value
$271.28K
Shares Held After
49,453
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$520.34
Total Value
$20.81K
Shares Held After
49,973
% of Holdings
0.1%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
5,044
Price
$50.02
Total Value
$252.29K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
3,795
Price
$49.32
Total Value
$187.17K
Shares Held After
5,044
% of Holdings
42.9%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
6,161
Price
$48.20
Total Value
$296.98K
Shares Held After
8,839
% of Holdings
41.1%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
1,200
Price
$79.94
Total Value
$95.93K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
600
Price
$79.24
Total Value
$47.55K
Shares Held After
1,200
% of Holdings
33.3%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
700
Price
$77.71
Total Value
$54.40K
Shares Held After
1,800
% of Holdings
28.0%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
1,596
Price
$18.95
Total Value
$30.25K
Shares Held After
339,392
% of Holdings
0.5%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.18
Total Value
$251.21K
Shares Held After
490,582
% of Holdings
3.7%
IONIS PHARMACEUTICALS INC (IONS)
Schneider Eugene — EVP, Chf Clinical Develop Ofcr
Shares
5,812
Price
$70.97
Total Value
$412.49K
Shares Held After
63,890
% of Holdings
8.3%
ALX ONCOLOGY HOLDINGS INC (ALXO)
Pinto Shelly — SVP, FINANCE AND CAO
Shares
903
Price
$2.17
Total Value
$1.96K
Shares Held After
86,805
% of Holdings
1.0%
ALX ONCOLOGY HOLDINGS INC (ALXO)
Lettmann Jason — Director
Shares
12,311
Price
$2.17
Total Value
$26.71K
Shares Held After
293,609
% of Holdings
4.0%
iBio, Inc. (IBIO)
Duran Felipe — Chief Financial Officer
Shares
24,835
Price
$2.02
Total Value
$50.13K
Shares Held After
35,974
% of Holdings
69.0%
iBio, Inc. (IBIO)
Brenner Martin — Director
Shares
12,336
Price
$2.02
Total Value
$24.92K
Shares Held After
30,652
% of Holdings
40.2%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
6,905
Price
$18.78
Total Value
$129.70K
Shares Held After
339,392
% of Holdings
2.0%
Aldeyra Therapeutics, Inc. (ALDX)
DOUGLAS RICHARD — Director
Shares
70,000
Price
$1.40
Total Value
$98.00K
Shares Held After
195,000
% of Holdings
35.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$532.90
Total Value
$21.32K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$531.90
Total Value
$127.66K
Shares Held After
40,553
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,431
Price
$531.20
Total Value
$760.15K
Shares Held After
40,793
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,608
Price
$530.20
Total Value
$852.56K
Shares Held After
42,224
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,950
Price
$529.32
Total Value
$1.03M
Shares Held After
43,832
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,241
Price
$528.31
Total Value
$655.63K
Shares Held After
45,782
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,515
Price
$527.30
Total Value
$798.86K
Shares Held After
47,023
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
876
Price
$526.27
Total Value
$461.01K
Shares Held After
48,538
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
599
Price
$525.08
Total Value
$314.52K
Shares Held After
49,414
% of Holdings
1.2%
INSMED Inc (INSM)
Lewis William — Director
Shares
4,533
Price
$144.11
Total Value
$653.25K
Shares Held After
301,185
% of Holdings
1.5%
INSMED Inc (INSM)
Lewis William — Director
Shares
4,537
Price
$143.42
Total Value
$650.70K
Shares Held After
305,718
% of Holdings
1.5%
Showing 51–100 of 1217 transactions (page 2 of 25)